Preliminary experiments suggest conolidine may possibly inhibit distinct ion channels, cutting down neuronal excitability and restricting suffering alerts. This mechanism is especially pertinent in neuropathic ache, wherever abnormal signaling will cause persistent soreness. Moreover, conolidine appears to impact G protein-coupled receptor (GPCR) p